Skip to main content
. 2017 Oct 18;8:747. doi: 10.3389/fphar.2017.00747

Figure 1.

Figure 1

Schematic diagram of the systems pharmacology infrastructure for identification of aging-associated indications by natural products. (A) Construction of drug-target network of natural products. (B) Manual curation of aging-associated genes. (C) Discovery of new anti-aging indications for natural products via network-based prediction. (D) Identification of new anti-aging mechanism-of-action via network analysis.